U.S. Marine and Shipping Stock News

Why Codexis Is Back on Investors’ Radar Codexis (CDXS) has drawn fresh attention after reporting fourth quarter 2025 results, with revenue of US$38.92 million and net income of US$9.6 million, alongside new full year 2026 revenue guidance. The company also recently signed an agreement to manufacture 50 grams of siRNA for a pharmaceutical partner using its ECO Synthesis platform, adding a commercial data point around its RNA manufacturing capabilities. See our latest analysis for Codexis. At a...

Cactus (NYSE:WHD) executives Joel Bender and Scott Bender have disclosed significant insider stock sales in March 2026. The President and the Chairman/CEO together sold more than 200,000 shares, according to recent SEC filings. There have been no insider purchases reported at Cactus over the past year, highlighting a one sided pattern of insider activity. Cactus, which trades on the NYSE under the ticker WHD, last closed at $46.36. The stock is down 7.3% over the past week and 19.1% over...

Why Imperial Petroleum is on investors’ radar right now Imperial Petroleum (IMPP) is getting fresh attention after reporting Q4 2025 results that showed higher sales and net income versus the same quarter a year earlier, alongside steady preferred dividend activity. See our latest analysis for Imperial Petroleum. The recent Q4 2025 report and ongoing preferred dividend payments have arrived alongside a 30 day share price return of 23.20% and a 1 year total shareholder return of 87.80%. This...

PEDEVCO (NYSEAM:PED) has expanded its board of directors and appointed Edward Geiser as a new director. Geiser will serve as Chairperson of the Nominating and Corporate Governance Committee. The company has also approved a 1 for 20 stock split, with implementation expected in the near term. PEDEVCO operates in the energy sector, where capital allocation, drilling decisions, and reservoir management are closely tied to governance quality. Adding an industry veteran like Edward Geiser to lead...

Coda Octopus Group recently reached a new 52-week high, reflecting past improvements in operational efficiency and a stronger position in its underwater technologies markets. This milestone, coupled with an increase in operating profit, highlights how the company’s business model and cost discipline may be reinforcing its industry standing. Next, we’ll explore how the improved operating profit profile could influence Coda Octopus Group’s existing investment narrative and future...

If you are wondering whether Griffon is starting to look attractively priced after its recent swings, or if the share price already reflects the story, this valuation review is designed to help you frame that question clearly. The stock closed at US$70.82, with a 7 day return of an 8.5% decline, a 30 day return of a 24.6% decline, a year to date return of a 5.6% decline, but a 1 year return of 2.9% and a 3 year return that is very large compared to the starting point. Recent price moves sit...

If you are wondering whether SIGA Technologies is attractively priced right now, this article will walk through what the current share price might be implying about its value. The stock closed at US$5.26 most recently, with returns showing a 9.3% decline over 7 days, a 20.8% decline over 30 days, a 16.1% decline year to date, but a 4.1% gain over 1 year and a 23.6% gain over 3 years that contrasts with a more modest 5.3% gain over 5 years. Recent price moves are sitting against a broader...

Director Carol Schneeberger has recently sold shares in Peoples Bancorp. The transactions involved insider stock sales with no corresponding insider purchases reported in the same period. The trades come with Peoples Bancorp shares last closing at $31.6 on the NasdaqGS under ticker NasdaqGS:PEBO. For investors tracking insider activity at Peoples Bancorp, the recent share sale by Director Carol Schneeberger adds a fresh data point to the story around NasdaqGS:PEBO. The stock last closed at...

KORU Medical Systems (KRMD) has just posted its FY 2025 third quarter numbers, with revenue of about US$10.4 million and a basic EPS loss of roughly US$0.02, underscoring that the company is still in the red. The company has seen revenue move from about US$8.2 million in Q3 FY 2024 to US$10.4 million in Q3 FY 2025, while quarterly basic EPS has ranged between a loss of roughly US$0.03 and US$0.02 over that period. As a result, investors are likely to focus on how quickly margins can tighten...

If you are wondering whether BrightView Holdings is attractively priced or just a value trap, you are in the right place to unpack what the current share price really reflects. The stock last closed at US$11.81, with returns of 7.2% decline over 7 days, 15.5% decline over 30 days, a 6.3% decline year to date, a 10.9% decline over 1 year, a 102.6% gain over 3 years and a 30.4% decline over 5 years. Taken together, this gives you a mixed picture of how sentiment has shifted over different...

Eastman Chemical (NYSE:EMN) has rolled out a new 2026 self help plan focused on deeper cost reductions and operational efficiency. The plan also targets expanded capital returns, signaling an intention to keep shareholder payouts in focus alongside internal improvements. Management is positioning the initiative as a material shift in how the company runs its business and allocates cash over the next few years. Eastman Chemical is launching this plan at a time when the stock has faced mixed...

McEwen (MUX) closed out FY 2025 with Q4 revenue of US$64.6 million and basic EPS of US$0.70, alongside net income of US$38.1 million, putting a clear marker on its latest financial run rate. Over the year, quarterly revenue ranged from US$35.7 million in Q1 to US$64.6 million in Q4, while basic EPS moved between a loss of US$0.12 and a gain of US$0.70, giving investors a wide view of how profitability has tracked against the top line. Overall, the results point to firmer margins in the latest...

Wondering whether Gibraltar Industries is starting to look like value at today’s price, or if the stock’s risks still outweigh the potential upside? This article is built to help you weigh that up using clear valuation checks. After closing at US$41.27, the stock has seen a 2.6% gain over the last 7 days. That sits against a 23.7% decline over 30 days and a 36.9% decline over the past year, with returns of 17.7% decline year to date, 11.2% decline over 3 years and 52.7% decline over 5...

If you are wondering whether Li Auto's current share price still reflects its long term potential, you are not alone. Many investors are asking what the stock is really worth right now. The stock closed at US$17.33, with returns of 1.0% over 7 days, a 9.7% decline over 30 days, roughly flat year to date at 0.5%, and a 36.9% decline over the last year, which has shifted how some investors may be thinking about both upside potential and risk. Recent news flow around Li Auto has focused on...

Cheney Brothers, a subsidiary of Performance Food Group, plans a $42.5 million expansion of its South Carolina distribution center. The project is expected to add new jobs in the region and support the integration of a recent acquisition. The expansion reflects Performance Food Group's focus on building out its distribution network and operational footprint. Performance Food Group (NYSE:PFGC) is drawing attention with this fresh capital commitment alongside a current share price of $88.18...

Albany International (NYSE:AIN) has been named an official partner for World Engineering Day for Sustainable Development 2026. The partnership spotlights the company’s role in materials science for sustainability and raises its profile with global engineering and policy audiences. For investors watching Albany International at a share price of $53.57, this new partnership adds a fresh layer of visibility that does not show up directly in recent price moves. The stock has seen a 26.3%...

Mercury Systems (NasdaqGS:MRCY) has acquired SolderMask, Inc., adding specialized manufacturing capabilities and intellectual property. The deal brings in skilled personnel and assets that directly support more than 20 active Mercury programs tied to critical defense work. The acquisition is intended to accelerate production efficiency and strengthen delivery commitments across key customer contracts. Mercury Systems, trading at $78.16, has seen a 68.0% return over the past year and a 69.1%...

If you are wondering whether Piper Sandler Companies' current share price really reflects its underlying worth, or if the recent run leaves room for value, this article walks through that question step by step. The stock last closed at US$282.30, with returns showing a 3.8% decline over 7 days, a 17.4% decline over 30 days, a 19.3% decline year to date, a 14.2% gain over 1 year and a very large 3 year and 5 year return. Recent coverage around Piper Sandler Companies has focused on its role...

In early March 2026, LifeMD, Inc. reported that it moved from a US$21.41 million annual net loss in 2024 to US$14.35 million net income in 2025, issued double‑digit revenue growth guidance for 2026, and highlighted expanding telehealth offerings including its oral Wegovy weight management launch with Novo Nordisk. This shift to profitability, combined with more than 322,000 active subscribers and growing GLP‑1 and women’s health programs, signals a business model that is scaling across...

WM Technology (MAPS) closed out FY 2025 with Q4 revenue of about US$43.1 million and a basic EPS loss of roughly US$0.03, while trailing twelve month EPS stood at around US$0.02 on revenue of roughly US$174.7 million. Over recent periods the company has seen quarterly revenue range between about US$42.2 million and US$47.7 million, with EPS moving from a profit of roughly US$0.03 per share in late 2024 to small profits through most of 2025 before the latest quarterly loss. This has left...

Immunic, Inc. recently secured a key European patent for its lead asset vidofludimus calcium, aligning protection with existing U.S. coverage and potentially extending exclusivity into the 2040s for chronic inflammatory and autoimmune indications. This expanded intellectual property protection materially underpins the company’s core therapeutic franchise by lengthening its runway to develop and, if approved, commercialize its main clinical asset. Against this backdrop, we’ll explore how the...

Precision BioSciences (DTIL) closed out FY 2025 with Q4 revenue of US$34.2 million and Basic EPS of US$1.01, alongside earnings from discontinued operations of US$0.9 million and net income excluding extra items of US$19.2 million. Over recent quarters, the company has seen revenue range from US$0.6 million in Q4 2024 to US$34.2 million in Q4 2025. Over the same period, quarterly Basic EPS has moved from a loss of US$2.22 in Q4 2024 to a profit of US$1.01 in Q4 2025. This sets up an earnings...

TIC Solutions (NYSE:TIC) has appointed Ben Heraud as its new CEO, succeeding long-serving leader Tal Pizzey. The company has also launched a $200 million share repurchase program. These changes were recently announced and have not been widely discussed in prior coverage. TIC Solutions is making these moves at a time when its share price is $7.25, with the stock showing a 40.3% decline over the past year and a 26.7% decline year to date. The new leadership and buyback plan arrive against...

EverCommerce (EVCM) has wrapped up FY 2025 with fourth quarter revenue of US$151.2 million and basic EPS of US$0.03, alongside net income from ongoing operations of US$5.7 million. This caps a trailing twelve month period with revenue of US$588.9 million and EPS of US$0.10. Over recent quarters the company has seen revenue range from US$142.3 million to US$151.2 million, with quarterly EPS between US$0.01 and US$0.03. Over the same period, trailing twelve month net income from ongoing...